Literature DB >> 14504405

The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences.

Akito Sakai1, Marisa St Claire, Kristina Faulk, Sugantha Govindarajan, Suzanne U Emerson, Robert H Purcell, Jens Bukh.   

Abstract

The role of the hepatitis C virus (HCV) p7 protein in the virus life cycle is not known. Previous in vitro data indicated that this 63-aa polypeptide is located in the endoplasmic reticulum and has two transmembrane domains (TMDs) connected by a cytoplasmic loop; the amino- and carboxyl-terminal tails are oriented toward the endoplasmic reticulum lumen. Furthermore, recent in vitro studies suggested that HCV p7 could function as a virus-encoded ion channel. It might therefore be a relevant target for future drug development. We studied the role of HCV p7 in vivo. Because HCV does not replicate efficiently in cell culture, we mutagenized p7 of an infectious genotype 1a cDNA clone and tested RNA transcripts of each mutant for infectivity in chimpanzees by intrahepatic transfection. Appropriate processing of mutant polypeptides was confirmed by studies in transfected mammalian cells. Mutants with deletions of all or part of p7 and a mutant with substitutions of two conserved residues in the cytoplasmic loop were not viable. Thus, p7 is essential for infectivity of HCV. A chimera in which the p7 of the 1a clone was replaced with p7 from an infectious genotype 2a clone also was not viable. This finding suggests a genotype-specific interaction between p7 and other genomic regions. To define which portions of p7 played the most significant role for this interaction, we tested three chimeras with the 1a backbone in which only specific domains of p7 had the 2a sequence. A p7 chimera with 2a tails and TMDs and the 1a cytoplasmic loop was not viable. A mutant with 2a tails and cytoplasmic loop and 1a TMDs also was not viable. However, a p7 chimera with 2a TMDs and cytoplasmic loop and 1a tails was viable. The transfected chimpanzee became viremic at week 2, and recovered viruses had the chimeric sequence. These data indicate that the amino- and/or carboxyl-terminal intraluminal tails of p7 contain sequences with genotype-specific function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504405      PMCID: PMC208812          DOI: 10.1073/pnas.1834545100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Subcellular localization and topology of the p7 polypeptide of hepatitis C virus.

Authors:  Séverine Carrère-Kremer; Claire Montpellier-Pala; Laurence Cocquerel; Czeslaw Wychowski; François Penin; Jean Dubuisson
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  The NB protein of influenza B virus is not necessary for virus replication in vitro.

Authors:  Masato Hatta; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives.

Authors:  Davor Pavlović; David C A Neville; Olivier Argaud; Baruch Blumberg; Raymond A Dwek; Wolfgang B Fischer; Nicole Zitzmann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

4.  Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial.

Authors:  Thomas Berg; Bernd Kronenberger; Holger Hinrichsen; Tilman Gerlach; Peter Buggisch; Eva Herrmann; Ulrich Spengler; Tobias Goeser; Samer Nasser; Karsten Wursthorn; Gerd R Pape; Uwe Hopf; Stefan Zeuzem
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

5.  Membrane topology of the hepatitis C virus NS2 protein.

Authors:  Ardath K Yamaga; Jing-Hsiung Ou
Journal:  J Biol Chem       Date:  2002-06-24       Impact factor: 5.157

6.  Thermodynamic and phylogenetic prediction of RNA secondary structures in the coding region of hepatitis C virus.

Authors:  Andrew Tuplin; Jonny Wood; David J Evans; Arvind H Patel; Peter Simmonds
Journal:  RNA       Date:  2002-06       Impact factor: 4.942

7.  The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine.

Authors:  Stephen D C Griffin; Lucy P Beales; Dean S Clarke; Oliver Worsfold; Stephen D Evans; Joachim Jaeger; Mark P G Harris; David J Rowlands
Journal:  FEBS Lett       Date:  2003-01-30       Impact factor: 4.124

8.  Expression and identification of hepatitis C virus polyprotein cleavage products.

Authors:  A Grakoui; C Wychowski; C Lin; S M Feinstone; C M Rice
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

9.  A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg.

Authors:  Olga Kalinina; Helene Norder; Sergey Mukomolov; Lars O Magnius
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

10.  Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees.

Authors:  Jens Bukh; Thomas Pietschmann; Volker Lohmann; Nicole Krieger; Kristina Faulk; Ronald E Engle; Sugantha Govindarajan; Max Shapiro; Marisa St Claire; Ralf Bartenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

View more
  88 in total

1.  NMR structure and ion channel activity of the p7 protein from hepatitis C virus.

Authors:  Roland Montserret; Nathalie Saint; Christophe Vanbelle; Andrés Gerardo Salvay; Jean-Pierre Simorre; Christine Ebel; Nicolas Sapay; Jean-Guillaume Renisio; Anja Böckmann; Eike Steinmann; Thomas Pietschmann; Jean Dubuisson; Christophe Chipot; François Penin
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

Review 2.  Hepatitis C virus: assembly and release of virus particles.

Authors:  Daniel M Jones; John McLauchlan
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

Review 3.  Ion channels as antivirus targets.

Authors:  Xin Liang; Zhi-Yuan Li
Journal:  Virol Sin       Date:  2010-07-28       Impact factor: 4.327

4.  Secondary structure, dynamics, and architecture of the p7 membrane protein from hepatitis C virus by NMR spectroscopy.

Authors:  Gabriel A Cook; Stanley J Opella
Journal:  Biochim Biophys Acta       Date:  2010-08-18

Review 5.  Comparative NMR studies demonstrate profound differences between two viroporins: p7 of HCV and Vpu of HIV-1.

Authors:  Gabriel A Cook; Hua Zhang; Sang Ho Park; Yan Wang; Stanley J Opella
Journal:  Biochim Biophys Acta       Date:  2010-08-18

6.  Transverse relaxation dispersion of the p7 membrane channel from hepatitis C virus reveals conformational breathing.

Authors:  Jyoti Dev; Sven Brüschweiler; Bo Ouyang; James J Chou
Journal:  J Biomol NMR       Date:  2015-02-28       Impact factor: 2.835

Review 7.  Viroporins customize host cells for efficient viral propagation.

Authors:  Kristina M Giorda; Daniel N Hebert
Journal:  DNA Cell Biol       Date:  2013-08-14       Impact factor: 3.311

8.  Plugging the holes in hepatitis C virus antiviral therapy.

Authors:  Stephen D C Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-28       Impact factor: 11.205

9.  Signal peptide cleavage and internal targeting signals direct the hepatitis C virus p7 protein to distinct intracellular membranes.

Authors:  Stephen Griffin; Dean Clarke; Christopher McCormick; David Rowlands; Mark Harris
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

10.  Limited hepatitis B virus replication space in the chronically hepatitis C virus-infected liver.

Authors:  S F Wieland; S Asabe; R E Engle; R H Purcell; F V Chisari
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.